DDO-2093

Overview

DDO-2093 is a potent MLL1-WDR5 protein-protein interaction inhibitor ( IC 50 =8.6 nM; K d =11.6 nM) with antitumor activity. DDO-2093 selectively inhibits the catalytic activity of MLL complex.

Application

Products | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > WDR5

Product Information

• Catalog No.: HY-132233
• CAS No.: 2250024-74-7
• Molecular Formula: C29H37ClFN9O3
• Molecular Weight: 614.11
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source